Clinical trial
Comparative Effectiveness in the Management of Irreversible Pulpitis
NCT04922229 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Effectiveness in the Management of Irreversible Pulpitis
- Lead sponsor
- University of Alabama at Birmingham
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 1, 2027
- Completion date
- December 31, 2031
- Enrollment
- 138 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
irreversible pulpitis